Check Before You Invest : MK Proteins Ltd

Q: Which industry/sub-sector does MK Proteins Ltd belong to?

MK Proteins Ltd belongs to the FMCG sector, operating specifically within the Edible Oil segment.

Q: Is MK Proteins Ltd a good quality company?

MK Proteins Ltd is a weak quality company, based on a inconsistent multi-year financial track record. This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

Q: Is MK Proteins Ltd undervalued or overvalued?

MK Proteins Ltd appears Somewhat Undervalued, as its key valuation ratios are lower than their past averages. Based on the industry it operates in, the relevant valuation ratios include one of the following, P/E, P/BV, P/Sales, EV/EBITDA or a combination of two or more. Valuation Ratios. Price to Earnings, Current: 23.26, Historic Median: 30.66. Price to Book, Current: 2.63, Historic Median: 4.78. Price to Sales, Current: 0.53, Historic Median: 1.24. EV to EBITDA, Current: 14.43, Historic Median: 21.86

Q: Is MK Proteins Ltd a good buy now?

MK Proteins Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Q: Revenue growth of MK Proteins Ltd?

MK Proteins Ltd revenue growth is 9.1% for FY-2025, which is above its 5-year CAGR of 6.64%, indicating faster growth.

Q: Gross Profit margin of MK Proteins Ltd?

MK Proteins Ltd Gross profit margin which is the profit after deduction of direct costs, is 4.4% for FY-2025, which is below its 5-year median of 5%, indicating decreasing margins.

Q: Operating Profit Margin of MK Proteins Ltd?

MK Proteins Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 4.68% for FY-2025, which is below its 5-year median of 5.41% indicating decreasing margins.

Q: Net Profit Margin of MK Proteins Ltd?

MK Proteins Ltd Net Profit Margin is 3.14% for FY-2025, is below its 5-year median of 3.47%, indicating decreasing margins. Profitability Metrics. Gross Profit Margin (%), Current: 4.4, Historic Median: 5. Operating Profit Margin (%), Current: 4.68, Historic Median: 5.41. Net Profit Margin (%), Current: 3.14, Historic Median: 3.47

Q: Return on Asset of MK Proteins Ltd?

MK Proteins Ltd Return on Asset is 7.3%, which is below its 5-year historical median of 11.45%, indicating deteriorated asset utilization efficiency.

Q: Return on capital employed (ROCE) of MK Proteins Ltd?

MK Proteins Ltd Return on capital employed is 13.46% for FY-2025, which is below its 5-year historical median of 19.78%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Snapshot

Q.1 Which industry/sub-sector does MK Proteins Ltd belong to?

MK Proteins Ltd belongs to the FMCG sector, operating specifically within the Edible Oil segment.

Q.2 Is MK Proteins Ltd a good quality company?

MK Proteins Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

Q.3 Is MK Proteins Ltd undervalued or overvalued?

MK Proteins Ltd appears Somewhat Undervalued, as its key valuation ratios are lower than their past averages.

Based on the industry it operates in, the relevant valuation ratios include one of the following, P/E, P/BV, P/Sales, EV/EBITDA or a combination of two or more.

Valuation Ratios	Current	5-year Historic Median
Price to Earnings	23.26	30.66
Price to Book	2.63	4.78
Price to Sales	0.53	1.24
EV to EBITDA	14.43	21.86

Q.4 Is MK Proteins Ltd a good buy now?

MK Proteins Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

A: What are the trends in revenue and profit margins?

Q.1 Revenue growth of MK Proteins Ltd?

MK Proteins Ltd revenue growth is 9.1% for FY-2025, which is above its 5-year CAGR of 6.64%, indicating faster growth.

Q.2 Gross Profit margin of MK Proteins Ltd?

MK Proteins Ltd Gross profit margin which is the profit after deduction of direct costs, is 4.4% for FY-2025, which is below its 5-year median of 5%, indicating decreasing margins.

Q.3 Operating Profit Margin of MK Proteins Ltd?

MK Proteins Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 4.68% for FY-2025, which is below its 5-year median of 5.41% indicating decreasing margins.

Q.4 Net Profit Margin of MK Proteins Ltd?

MK Proteins Ltd Net Profit Margin is 3.14% for FY-2025, is below its 5-year median of 3.47%, indicating decreasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin (%)	4.4	5
Operating Profit Margin (%)	4.68	5.41
Net Profit Margin (%)	3.14	3.47

B: Does the business utilize capital efficiently?

Q.5 Return on Asset of MK Proteins Ltd?

MK Proteins Ltd Return on Asset is 7.3%, which is below its 5-year historical median of 11.45%, indicating deteriorated asset utilization efficiency.

Q.6 Return on capital employed (ROCE) of MK Proteins Ltd?

MK Proteins Ltd Return on capital employed is 13.46% for FY-2025, which is below its 5-year historical median of 19.78%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.7 Return on Equity (ROE) of MK Proteins Ltd?

MK Proteins Ltd Return on equity is 12.87% for FY-2025, which is below its 5-year historical median of 24.44%, indicating the business is making worse use of its shareholders capital.

Q.8 Cash conversion cycle of MK Proteins Ltd?

MK Proteins Ltd Cash conversion cycle is 109 days, above its 5-year historical median of 91 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover (x)	2.33	3.3
ROE (%)	12.87	24.44
ROCE (%)	13.46	19.78
Cash Conversion Cycle	109 days	91 days

C: How much debt does the business have and is it at a sustainable level?

Q.9 Debt to Equity ratio of MK Proteins Ltd?

MK Proteins Ltd Debt-to-Equity ratio is 0.54, which is above the industry average of 0.15, indicating higher debt levels in the industry.

Q.10 Debt to cash flow from operations of MK Proteins Ltd?

MK Proteins Ltd Debt to cash flow from operations is -2.34, which is at a unhealthy level.

Ownership & governance

D: Promoter shareholding and pledge status of MK Proteins Ltd?

Q.1 Promoter shareholding and pledge status of MK Proteins Ltd?

Promoters hold 74.82% of the MK Proteins Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

E: How does MK Proteins Ltd performance compare with that of its Peers?

Q.1 Revenue growth of MK Proteins Ltd vs industry peers?

MK Proteins Ltd revenue CAGR is 6.64%, compared to the industry median CAGR of 5.73%, indicating faster growth and gaining its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth (%)	9.1	5.7
Gross Profit Growth (%)	-25	18.9
Operating Profit Growth (%)	-29.4	15.6
Net Profit Growth (%)	-27.3	22

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover (x)	2.33	2.52
ROE (%)	12.87	7.9
ROCE (%)	13.46	11.17
Cash Conversion Cycle (days)	109.05	45

Valuation & price assessment

Q.1 Stock return of MK Proteins Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of -41.93% based on the current price.

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-41.9%	-81.1%	-11.6%

Q.2 Valuation ratios of MK Proteins Ltd vs historical?

The current P/E ratio of 23.26 is lower than its historical median of 30.66, indicating that the stock is trading below its historical average valuation.

Q.3 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	23.26	30.66	29.43
Price to Book	2.63	4.78	2.26
Price to Sales	0.53	1.24	0.65
EV to EBITDA	14.43	21.86	16.89

Check more companies

1. AWL Agri Business

2. Gokul Agro Resources

3. CIAN Agro Industries

8. Gokul Refoils & Solv

9. Ajanta Soya

10. MK Proteins

Check trending companies

1. Narayana Hrudayalaya Ltd.

2. Laurus Labs Ltd.

3. The Federal Bank Ltd.

4. UCO Bank

5. Bank Of Baroda